These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 4578564

  • 81. Autoantibody activity against evolutionary conserved juxtanuclearly arranged antigen in mice with tumors induced by a progressor Moloney sarcoma virus transformant.
    Weiland E, Weiland F, Thiel HJ.
    Exp Cell Biol; 1984; 52(5):300-10. PubMed ID: 6090238
    [Abstract] [Full Text] [Related]

  • 82. Immunotherapy of primary Moloney sarcoma-virus-induced tumors.
    Fefer A.
    Int J Cancer; 1970 May 15; 5(3):327-37. PubMed ID: 5452066
    [No Abstract] [Full Text] [Related]

  • 83. Prevention of murine sarcoma virus oncogenesis in offspring of immunized female mice.
    Chieco-Bianchi L, Collavo D, Biasi G, Colombatti A.
    Br J Cancer; 1973 Sep 15; 28(3):238-44. PubMed ID: 4795530
    [Abstract] [Full Text] [Related]

  • 84. The effect of immunosuppression on oncogenesis by murine sarcoma virus.
    Zisblatt M, Lilly F.
    Proc Soc Exp Biol Med; 1972 Dec 15; 141(3):1036-40. PubMed ID: 4672103
    [No Abstract] [Full Text] [Related]

  • 85. Combined effects of BCG or Candida albicans (CA) with antitumor agents against a virus-induced lymphoma in mice.
    Bistoni F, Marconi P, Pitzurra M, Frati L, Spreafico F, Goldin A, Bonmassar E.
    Eur J Cancer (1965); 1979 Nov 15; 15(11):1305-14. PubMed ID: 393515
    [No Abstract] [Full Text] [Related]

  • 86. Genetic control of antibody responses to Moloney virus in rats.
    Jones JM, Günther E, Soderberg FB.
    Leuk Res; 1982 Nov 15; 6(1):127-9. PubMed ID: 7070110
    [No Abstract] [Full Text] [Related]

  • 87. Cellular mechanisms underlying the adjuvant activity of Candida albicans in a mouse lymphoma model.
    Marconi P, Cassone A, Tissi L, Baccarini M, Puccetti P, Garaci E, Bonmassar E, Bistoni F.
    Int J Cancer; 1982 Apr 15; 29(4):483-8. PubMed ID: 7044994
    [Abstract] [Full Text] [Related]

  • 88.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 89.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 90.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 91.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 92.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 93. The effect of immune modulators on the oncogenic process: adjuvant effect of Staphylococcus aureus in treating murine leukemia.
    Chirigos MA, Theodore T.
    Ann N Y Acad Sci; 1976 Apr 15; 276():513-9. PubMed ID: 1071976
    [No Abstract] [Full Text] [Related]

  • 94.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 95.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 96. Proceedings: The superadditive effects of x-rays and adoptively transferred immunity on mouse BP8 tumour cells in vivo.
    McBurney J, Munro TR.
    Br J Cancer; 1975 Dec 15; 32(6):764. PubMed ID: 1220793
    [No Abstract] [Full Text] [Related]

  • 97. Opsonization of cells by isoantibody in vitro.
    BENNETT B, OLD LJ, BOYSE EA.
    Nature; 1963 Apr 06; 198():10-2. PubMed ID: 13967460
    [No Abstract] [Full Text] [Related]

  • 98.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 99.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 100. Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice.
    Fefer A, McCoy JL, Perk K, Glynn JP.
    Cancer Res; 1968 Aug 06; 28(8):1577-85. PubMed ID: 4876979
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.